Meet the Israeli athletes heading to the Paris Paralympics
15 paralympians have already been confirmed to join Israel’s delegation headed to the Paris Paralympics on August 28.
15 paralympians have already been confirmed to join Israel’s delegation headed to the Paris Paralympics on August 28.
Natural killer cells, essential for fighting cancer, often malfunction due to exhaustion. A promising new technique could rejuvenate them.
Sheba Medical Center scientists develop algorithm that predicts likelihood of a newly admitted patient suffering a potentially life-threatening PE.
Big pharma giant shells out $1.7 billion for Israeli company V-Wave, and expects to earn enough to purchase a gumball — in the short term, at least.
A study by Hebrew University of Jerusalem offers first empirical evidence that genetic diversity plays a significant role in group judgment.
Regional Medicare contractors in 13 states approve reimbursement for a clinically validated virtual reality training intervention from GaitBetter.
Food delivery service in North Carolina and Texas, with partners such as Jersey Mike Subs and Little Caesars, is now largest US operation of its kind.
Birds aren’t the only creatures that favor this lush nature reserve for their migration stopovers.
Israel Olympic CEO: ‘We won 7 medals after what happened to us as a country on October 7. There is nothing more symbolic than that.’
Archeologists uncover part of the quarry whose stones are believed to have been used in construction works of King Herod the Great.
Hi Auto’s AI voice bot, Bo-Linda, will handle customer orders at hundreds of Bojangles drive-thrus with over 95% accuracy.
Nutritional imbalances affect survival, reproductive success and offspring health of bees, which in turn impact pollination of our food supply.
Researchers found significant disparities between male and female patients, even those who reported identical levels of pain.
Israeli scientists propose nonsurgical way to check body’s level of visceral adipose tissue inflammation as a risk factor for cardiometabolic disease.
Against all odds, in H1/2024 the total amounts and number of deals grew for the first time since H2/2021 according to IVC-LeumiTech report.